Literature DB >> 2395162

Chromosomal radiosensitivity of lymphocytes from Alzheimer's disease patients.

S E Tobi1, J E Moquet, A A Edwards, D C Lloyd, R F Itzhaki.   

Abstract

We have examined chromosome aberrations in gamma irradiated (3 Gy) lymphocytes from five patients with Alzheimer's disease (AD). In each case, the number of dicentrics was significantly higher than the number in irradiated lymphocytes from five age matched normal subjects, the mean value for AD cells being about 25% higher. There was no significant difference in number of acentrics between AD and normal cells. Examination of the number of first, second, and third division metaphases, using fluorescence plus Giemsa staining, indicated that there was no difference in cycling time between AD and normal cells, and that after irradiation both groups showed the same mitotic delay. The similarity of our findings to those of others with irradiated Down's syndrome cells (from adult patients) is discussed.

Entities:  

Mesh:

Year:  1990        PMID: 2395162      PMCID: PMC1017181          DOI: 10.1136/jmg.27.7.437

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  24 in total

1.  DNA repair and frequency of x-ray and u.v.-light induced chromosome aberrations in leukocytes from patients with Down's syndrome.

Authors:  B Lambert; K Hansson; T H Bui; F Funes-Cravioto; J Lindsten
Journal:  Ann Hum Genet       Date:  1976-01       Impact factor: 1.670

2.  New Giemsa method for the differential staining of sister chromatids.

Authors:  P Perry; S Wolff
Journal:  Nature       Date:  1974-09-13       Impact factor: 49.962

3.  No interaction between ultraviolet and X irradiation on chromosome aberrations in cells with trisomy 21.

Authors:  M Holmberg
Journal:  Nature       Date:  1974-05-31       Impact factor: 49.962

4.  In vitro chromosomal radiosensitivity in patients and in carriers with abnormal non-Down's syndrome karyotypes.

Authors:  M Higurashi; P E Conen
Journal:  Pediatr Res       Date:  1972-05       Impact factor: 3.756

5.  Chromosome constitution and its bearing on the chromosomal radiosensitivity in man.

Authors:  M S Sasaki; A Tonomura; S Matsubara
Journal:  Mutat Res       Date:  1970-12       Impact factor: 2.433

6.  In vitro chromosomal radiosensitivity in "chromosomal breakage syndromes".

Authors:  M Higurashi; P E Conen
Journal:  Cancer       Date:  1973-08       Impact factor: 6.860

7.  X-ray-induced chromosome aberrations in Down lymphocytes: an explanation of their increased sensitivity.

Authors:  R J Preston
Journal:  Environ Mutagen       Date:  1981

8.  No elevated sister chromatid exchange in Alzheimer's disease.

Authors:  R Sulkava; L Rossi; S Knuutila
Journal:  Acta Neurol Scand       Date:  1979-03       Impact factor: 3.209

9.  The incidence of unstable chromosome aberrations in peripheral blood lymphocytes from unirradiated and occupationally exposed people.

Authors:  D C Lloyd; R J Purrott; E J Reeder
Journal:  Mutat Res       Date:  1980-08       Impact factor: 2.433

10.  Chromosome damage in G0 X-irradiated lymphocytes from patients with hereditary retinoblastoma.

Authors:  J E Morten; D G Harnden; A M Taylor
Journal:  Cancer Res       Date:  1981-09       Impact factor: 12.701

View more
  3 in total

1.  Fluorescent light-induced chromatid breaks distinguish Alzheimer disease cells from normal cells in tissue culture.

Authors:  R P Parshad; K K Sanford; F M Price; L K Melnick; L E Nee; M B Schapiro; R E Tarone; J H Robbins
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

2.  Damage, repair, and mutagenesis in nuclear genes after mouse forebrain ischemia-reperfusion.

Authors:  P K Liu; C Y Hsu; M Dizdaroglu; R A Floyd; Y W Kow; A Karakaya; L E Rabow; J K Cui
Journal:  J Neurosci       Date:  1996-11-01       Impact factor: 6.167

Review 3.  Possible factors in the etiology of Alzheimer's disease.

Authors:  R F Itzhaki
Journal:  Mol Neurobiol       Date:  1994 Aug-Dec       Impact factor: 5.590

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.